# Prestige Consumer Healthcare Inc. (PBH) fundamentals

Data as of 2026-09-08. NYSE, United States. Sector: Healthcare / Health Care Providers & Services. Price $52.26, market value $2.5 billion.

## Valuation
- **P/E (trailing): 14.6×** (5-yr avg 16.4×, 3-yr avg 17.5×). Prestige Consumer Healthcare Inc. trades at 14.6× trailing earnings, close to its own five-year average of 16.4×. The Healthcare median in the September 2026 study was 28.5×. Forward P/E is 10.3×, lower than trailing, so analysts expect earnings to grow.
- **Price / sales: 2.2×**. Each dollar of revenue is priced at 2.2×.
- **Price / book: 1.3×**. The shares trade at 1.3× book value; book value is a meaningful part of the valuation.
- **EV / EBITDA: 10.6×**. Enterprise value is 10.6× operating earnings before depreciation, the multiple that ignores how the company is financed.
- **Free-cash-flow yield: 9.5%** (5-yr avg 7.4%). Free cash flow equals 9.5% of the market value, above its five-year average of 7.4%, so the shares are cheaper on cash than they have usually been. Above 5% is generally attractive.
- **Earnings yield: 6.8%**. The inverse of the P/E: 6.8% of the price is earned each year.

## Profitability
- **Gross margin: 53.5%**. Prestige Consumer Healthcare Inc. keeps 53.5% of revenue after the direct cost of what it sells.
- **Operating margin: 26.3%**. 26.3% of revenue is left after running the business, an exceptional level.
- **Net margin: 17.5%**. 17.5% of each dollar of sales reaches the bottom line.
- **Return on equity: 10.1%**. 10.1% on shareholders' equity is solid.
- **Return on invested capital: 8.1%**. Return on all capital, debt included, is 8.1%.
- **Return on assets: 4.9%**. Each dollar of assets produces 4.9% of profit.

## Growth
- **Revenue growth (1 yr): -4.3%** (3-yr -1.2%/yr, 5-yr 2.9%/yr). Revenue fell 4.3% over the last year, against 2.9% a year compounded over five years: growth is slowing.
- **EPS growth (1 yr): -8.9%** (5-yr 3.8%/yr). Earnings per share fell 8.9%, roughly in step with revenue.
- **Free-cash-flow growth (3 yr): 3.6%/yr**. Free cash flow has compounded at 3.6% a year over three years.

## Financial health
- **Debt to equity: 0.53**. Debt is 0.53 times equity, moderate leverage.
- **Net debt / EBITDA: 2.9×**. It would take 2.9 years of operating earnings to repay net borrowings, within the comfortable range.
- **Altman Z-score: 2.28**. A Z-score of 2.28 is in the grey zone; not distressed, not clearly safe.
- **Piotroski F-score: 5/9**. 5 of 9 checks pass: mixed.

## Dividends
- **Dividend: none**. Prestige Consumer Healthcare Inc. does not currently pay a dividend.

## Price and momentum
- **Total return (1 yr): -21.7%** (YTD -15.3%, 3-mo 10.8%). The shares are down 21.7% over twelve months including dividends.
- **From 52-week high: -26.5%** (22.6% above the low). Trading 26% below its 52-week high.
- **200-day average: below**. The price sits below its 200-day moving average, the usual definition of a downtrend.
- **RSI (14-day): 53**. An RSI of 53 is neutral.
- **Beta (1 yr): 0.03** (volatility 31%). Beta of 0.03 against the S&P 500: the shares move much less than the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=PBH · Page: https://foliofundamentals.com/stocks/pbh

Not investment advice.